SHANGHAI, Oct. 16, 2025 /PRNewswire/ -- Unixell Biotech, a clinical-stage bitotech company focused on developing innovative cell therapies for Parkinson's disease (PD) and other neurological disorders ...
The MarketWatch News Department was not involved in the creation of this content. SHANGHAI, Oct. 16, 2025 /PRNewswire/ -- Unixell Biotech, a clinical-stage bitotech company focused on developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback